(Q28344279)

2

0 references

M S DeStefano

3

0 references

T S Harpster

4

0 references

A J Chmielewski

5

0 references

M H Cynamon

Antimicrobial Agents and Chemotherapy

6

0 references

language of work or name

English

0 references

publication date

June 2000

0 references

published in

0 references

volume

44

0 references

issue

6

0 references

page(s)

1458-62

0 references

cites work

Evaluation of once-weekly therapy for tuberculosis using isoniazid plus rifamycins in the mouse aerosol infection model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89897

Low-dose aerosol infection model for testing drugs for efficacy against Mycobacterium tuberculosis

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89897

In vitro bactericidal and in vivo therapeutic activities of a new rifamycin derivative, KRM-1648, against Mycobacterium tuberculosis

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89897

Activity of KRM-1648 in combination with isoniazid against Mycobacterium tuberculosis in a murine model

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89897

Activity of KRM-1648, a new benzoxazinorifamycin, against Mycobacterium tuberculosis in a murine model

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89897

A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89897

The Chemotherapy of Pulmonary Tuberculosis: A Review

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89897

Chemotherapeutic activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium tuberculosis in C57BL/6 mice

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89897

Once-weekly rifapentine-containing regimens for treatment of tuberculosis in mice.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89897

Supervised six-months treatment of newly diagnosed pulmonary tuberculosis using isoniazid, rifampin, and pyrazinamide with and without streptomycin

27 November 2018

1 reference

12 December 2020

Successful intermittent treatment of smear-positive pulmonary tuberculosis in six months: a cooperative study in Poland

1 reference

12 December 2020

How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis

1 reference

12 December 2020

Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis

1 reference

12 December 2020

10.1128/AAC.44.6.1458-1462.2000

Identifiers

DOI

0 references

Fatcat ID

release_zmhk2zipnrertek7claavxbg7m

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zmhk2zipnrertek7claavxbg7m

24 November 2022